News in brief: Bioxyne raises A$3m for European expansion; Cann Group receives $750k by Steve Jones March 21, 2025March 24, 2025 Brisbane-based manufacturer Bioxyne has received commitments to raise A$3 million as it looks to fund European […]
Pastilles drive Bioxyne to first-half profit after revenue climbs 171% by Steve Jones March 3, 2025March 3, 2025
Bioxyne upgrades revenue forecast on back of record Q2 by Martin Lane January 24, 2025January 29, 2025
Bioxyne sees sharp revenue growth as shares jump after strong quarter by Steve Jones October 17, 2024February 25, 2025
Bioxyne forecasts doubling of revenue amid ‘$100m gummy opportunity’ by Steve Jones September 26, 2024September 26, 2024
Montu named as customer behind ‘$28m’ gummy deal as Bioxyne resumes trading on ASX by Steve Jones September 18, 2024September 19, 2024
Financial results: Rua Bioscience; Elixinol Wellness; Argent Biopharma; Wellnex Life; InhaleRx; Bioxyne by Martin Lane and Steve Jones September 2, 2024September 3, 2024
Company news: Rua Bioscience; Avecho; Bioxyne/BLS; iX Biopharma; Ecofibre; Zelira by Steve Jones and Martin Lane August 28, 2024January 13, 2025
Company news: Avecho; Bioxyne; Elixinol Wellness; IDT Australia; Melodiol Global Health; Zelira by Steve Jones July 31, 2024November 25, 2024
